Swift Outpatient Alternatives for Rapid Stabilization

Last updated: March 24, 2025
Sponsor: University of Washington
Overall Status: Active - Recruiting

Phase

N/A

Condition

Suicide

Treatment

Lethal Means Safety

CAMS Single Session Consultation

Caregiver Skills Training

Clinical Study ID

NCT05996172
STUDY00016898
P50MH129708
  • Ages 13-21
  • All Genders

Study Summary

The goal of this clinical trial is to improve the effective outpatient management of acute youth suicide risk by optimizing intervention components to build an efficient, evidence-based intervention that is responsive to the needs of, and coordinated with, providers in primary care settings. The main questions are:

  1. What is the strongest combination of SOARS components associated with reduction in youth suicidal thoughts and behavior (STB)?

  2. Do age and STB history moderate the impact of the effects of the SOARS intervention components?

  3. Do therapeutic alliance, youth and caregiver self-efficacy account for changes in youth STBs?

  4. What helps medical outpatient providers refer to SOARS and continue care after SOARS?

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Acute suicidal thoughts or past month suicide attempt as reported on positiveresponses to the Ask Suicide Screening Questionnaire (ASQ),

Exclusion

Exclusion Criteria:

  • urgent medical care secondary to self-injurious behavior, psychosis, eating disorderthat requires full or partial inpatient care, or

  • intellectual disability warranting a different treatment pathway;

  • limited English, Spanish, Vietnamese, or Chinese proficiency that would interferewith ability to complete study assessments;

  • unwillingness to participate in psychotherapy,

  • caregiver unwilling or ineligible to participate;

  • and previous enrollment in SOARS program or other P50 project as to not confuselongitudinal follow-up.

Study Design

Total Participants: 184
Treatment Group(s): 4
Primary Treatment: Lethal Means Safety
Phase:
Study Start date:
November 09, 2023
Estimated Completion Date:
January 31, 2028

Study Description

The investigators are comparing different treatment sequences for suicidal thoughts and behaviors. The treatment package families are assigned will be determined by randomization.

All participants will receive 1 session of Collaborative Assessment and Management of Suicidality (CAMS) and care management. CAMS treatment primarily focuses on working with a therapist to understand the reasons why the participants are thinking about suicide Additional components which the participant may be randomly assigned to receive include coping skills training for youth, skills training for parents, and additional safety strategies. Each treatment type is designed to help adolescents and young adults with suicide risk.

Participants will be randomly assigned to an intervention sequence for a minimum of 1 session (120 minutes) and maximum of 8 sessions (440 minutes, divided across separate youth and caregiver components).

Caregivers will receive at least 1 session and a maximum of 4 sessions. Depending on the randomization, caregivers may be assigned to receive skills related to caregiving and safe storage of items that could be used for harm.

To see how the treatment is going participants will receive study assessments at the beginning of the study, 1-month, and 2-months. Study assessments will ask about demographics, suicide attempts, suicidal ideation, non-suicidal self-injury, experiences with treatment, substance use, and social experiences. The research team will also collect information from medical records.

Connect with a study center

  • Seattle Children's

    Seattle, Washington 98199
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.